Search clinical trials for: Estrogen receptor positive
Total 29763 results
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, Belgium, Germany, Italy, Austria, Japan, Australia, Canada, Sweden, Switzerland, United Kingdom, Spain, Denmark, France, Ireland, Israel, Netherlands, Korea, Republic of, Norway
-
Dana-Farber Cancer InstituteNovartis; Beth Israel Deaconess Medical CenterCompleted
-
Lynn HenryCompletedBreast Cancer | ArthralgiaUnited States
-
M.D. Anderson Cancer CenterSusan G. Komen Breast Cancer FoundationCompleted
-
Mayo ClinicNational Cancer Institute (NCI)Terminated
-
Ottawa Hospital Research InstituteCanadian Breast Cancer FoundationCompleted
-
Yale UniversityCompletedBreast Cancer | Early Stage Estrogen Receptor (ER) Positive Breast CancerUnited States
-
Novartis Healthcare A/SCompleted
-
Midwest Fertility SpecialistsCompleted
-
PfizerTerminatedBreast NeoplasmsUnited States, Canada, Netherlands, Brazil, Belgium, United Kingdom, Argentina, Italy, Sweden
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Intarcia TherapeuticsCompletedBreast Neoplasms | Neoplasms, Hormone-dependentUnited States, Canada, Russian Federation, Ukraine
-
University Hospital, ToursInstitut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative TumorFrance
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedEstrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyWithdrawn
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
NSABP Foundation IncNational Cancer Institute (NCI)Unknown
-
International Breast Cancer Research FoundationCompletedBreast CancerPhilippines, Morocco, Vietnam
-
Washington University School of MedicineNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
NanoString Technologies, Inc.Hospital General Universitario Gregorio Marañon; Cedar Associates LLC; Illumina... and other collaboratorsCompleted
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerSweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
-
Washington University School of MedicineCompletedBreast NeoplasmsUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Merck Sharp & Dohme LLC; Commonwealth Foundation for Cancer...Terminated
-
Washington University School of MedicineWithdrawn
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCCompleted
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Fengxi SuUnknownBreast Cancer Patients in Premenopausal | Estrogen and/or Progesterone Receptor PositiveChina
-
Zekai Tahir Burak Women's Health Research and Education...Unknown
-
Novartis PharmaceuticalsCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Withdrawn
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
Organisation for Oncology and Translational ResearchUnknownHormone Receptor Positive Malignant Neoplasm of BreastChina
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
Asan Medical CenterKorean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
National Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Legacy Health SystemCompleted
-
German Breast GroupCompleted
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Vanderbilt-Ingram Cancer CenterWithdrawnMetastatic Breast Cancer
-
Fudan UniversityUnknown
-
Imperial College LondonCompletedBreast CancerUnited Kingdom, Korea, Republic of
-
Institut Català d'OncologiaUnknown
-
Azienda Ospedaliero-Universitaria di ModenaUnknown
-
Anglo Celtic Cooperative Oncology GroupCompletedBreast Cancer | Infertility | Menopausal SymptomsUnited Kingdom
-
AstraZenecaCompletedHormon Receptor Positive Breast CancerSerbia